Alnylam Pharmaceuticals (ALNY) Assets Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.73% |
| Dec 31, 2025 | 17.13% |
| Sep 30, 2025 | 15.38% |
| Jun 30, 2025 | 13.88% |
| Mar 31, 2025 | 10.18% |
| Dec 31, 2024 | 10.71% |
| Sep 30, 2024 | 9.53% |
| Jun 30, 2024 | 17.85% |
| Mar 31, 2024 | 12.75% |
| Dec 31, 2023 | 7.99% |
| Sep 30, 2023 | 8.59% |
| Jun 30, 2023 | 2.16% |
| Mar 31, 2023 | -1.21% |
| Dec 31, 2022 | -2.66% |
| Sep 30, 2022 | 1.81% |
| Jun 30, 2022 | -5.10% |
| Mar 31, 2022 | 5.48% |
| Dec 31, 2021 | 6.93% |
| Sep 30, 2021 | 4.99% |
| Jun 30, 2021 | 4.00% |
| Mar 31, 2021 | 42.80% |
| Dec 31, 2020 | 42.25% |
| Sep 30, 2020 | 30.12% |
| Jun 30, 2020 | 24.22% |
| Mar 31, 2020 | 13.19% |
| Dec 31, 2019 | 52.09% |
| Sep 30, 2019 | 51.68% |
| Jun 30, 2019 | 51.81% |
| Mar 31, 2019 | 4.72% |
| Dec 31, 2018 | -21.05% |
| Sep 30, 2018 | 23.37% |
| Jun 30, 2018 | 24.76% |
| Mar 31, 2018 | 69.60% |
| Dec 31, 2017 | 57.96% |
| Sep 30, 2017 | 3.46% |
| Jun 30, 2017 | 3.77% |
| Mar 31, 2017 | -13.90% |
| Dec 31, 2016 | -8.92% |
| Sep 30, 2016 | -8.58% |
| Jun 30, 2016 | -9.71% |
| Mar 31, 2016 | -19.15% |
| Dec 31, 2015 | 28.43% |
| Sep 30, 2015 | 45.60% |
| Jun 30, 2015 | 48.24% |
| Mar 31, 2015 | 50.77% |
| Dec 31, 2014 | 156.72% |
| Sep 30, 2014 | 120.41% |
| Jun 30, 2014 | 123.25% |
| Mar 31, 2014 | 129.08% |
| Dec 31, 2013 | 46.26% |
| Sep 30, 2013 | 38.82% |
| Jun 30, 2013 | 45.24% |
| Mar 31, 2013 | 38.58% |
| Dec 31, 2012 | 1.99% |
| Sep 30, 2012 | 3.91% |
| Jun 30, 2012 | -6.56% |
| Mar 31, 2012 | -7.79% |
| Dec 31, 2011 | -28.31% |
| Sep 30, 2011 | -24.81% |
| Jun 30, 2011 | -22.57% |
| Dec 31, 2010 | -18.31% |